OrbiMed Advisors acquires 1.940.000 Braveheart Bio common shares worth $ 34,92 juta
BRVE•OrbiMed increases indirect stake in Braveheart Bio
- Braveheart Bio reported that OrbiMed Advisors increased its indirect ownership to 11,901,826 common shares.
- That position includes 9,132,420 common shares from conversion of Series A Preferred Stock.
- OrbiMed also bought 1,940,000 common shares at $18 per share.
Related News
BridgeBio Oncology Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
BBOT•
Auburn National net earnings naik 34% menjadi USD 4,5 juta pada 1H FY26; revenue naik 9% menjadi USD 17,39 juta pada 1H FY26
AUBN•
